Ashiq Mubarack

Stock Analyst at Citigroup

(2.43)

# 2,394

Out of 4,670 analysts

3

Total ratings

66.67%

Success rate

10.79%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Ashiq Mubarack

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	MRSN Mersana Therapeutics	Maintains: Buy	$6 → $5	$2.04	+145.10%	2	Aug 27, 2024
	DRTS Alpha Tau Medical	Initiates: Buy	$8	$2.32	+244.83%	1	Dec 15, 2023

Mersana Therapeutics

Aug 27, 2024

Maintains: Buy

Price Target: $6 → $5

Current: $2.04

Upside: +145.10%

Alpha Tau Medical

Dec 15, 2023

Initiates: Buy

Price Target: $8

Current: $2.32

Upside: +244.83%